๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This phase I/II trial studies the side effects, best dose, and effectivenes...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-06-29
Trial ID
NCT04939272
Treatments Being Tested
This phase II trial studies how well copanlisib hydrochloride and nivolumab...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-12-13
Trial ID
NCT03484819
Treatments Being Tested
This phase II MATCH treatment trial identifies the effects of copanlisib hy...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2018-06-20
Trial ID
NCT05490771
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
The purpose of this study is to assess whether copanlisib in combination wi...
Status
Terminated
Location
Ironwood Physicians P.C. DBA Ironwood Cancer & Res. Ctr.
Start Date
2016-01-06
Trial ID
NCT02626455
This phase II trial compares copanlisib and olaparib to standard of care ch...
Status
Withdrawn
Location
University of Colorado Hospital
Start Date
2022-06-30
Trial ID
NCT05295589
This phase I/II trial studies the side effects and best dose of copanlisib ...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2020-07-17
Trial ID
NCT04317105
This pilot phase I trial studies the side effects of direct tumor microinje...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2018-03-27
Trial ID
NCT03432741
This phase Ib trial seeks to identify the side effects and best dose of the...
Status
Active Not Recruiting
Location
Keck Medicine of USC Buena Park
Start Date
2019-11-21
Trial ID
NCT03842228
This phase I/II trial studies the side effects and best dose of copanlisib ...
Status
Active Not Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2021-03-01
Trial ID
NCT04345913